In fact, randomized, controlled trials of Se supplementation in elderly patients [16] and pregnant women [17] from the UK, who have lower baseline Se than US subjects, did not result in increased T2D risk, as determined by serum adiponectin concentration. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.